Factbox: Key upcoming clinical trials of hydroxychloroquine, touted by Trump, for COVID-19

The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to potential safety risks but other studies testing the medicine are continuing.